Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?

Gittes, 1991, Carcinoma of prostate, New Engl. J. Med., 324, 236, 10.1056/NEJM199101243240406 Sandberg, 1992, Chromosomal abnormalities and related events in prostate cancer, Hum. Pathol., 23, 368, 10.1016/0046-8177(92)90083-F Miller, 1994, Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration, J. Urol., 151, 1587 Karp, 1995, Molecular foundations of cancer: new targets for intervention, Nat. Med., 1, 309, 10.1038/nm0495-309 Sidransky, 1992, Clonal origin of bladder cancer, New Engl. J. Med., 326, 737, 10.1056/NEJM199203123261104 Noguchi, 1994, Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis, Cancer, 74, 872, 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P Tsao, 1993, Molecular genetic evidence for a unifocal origin of human serous ovarian carcinomas, Gynecol. Oncol., 48, 5, 10.1006/gyno.1993.1002 Nowell, 1976, The clonal evolution of tumor cell populations, Science, 194, 23, 10.1126/science.959840 Ruijter, 1996, Histological grade heterogeneity in multifocal prostate cancer, J. Pathol., 180, 295, 10.1002/(SICI)1096-9896(199611)180:3<295::AID-PATH663>3.0.CO;2-W Karp, 1996, Prostate cancer prevention: investigational approaches and opportunities, Cancer Res., 56, 5547 Warzynski, 1995, DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma — necessitating multiple site analysis, Prostate, 27, 329, 10.1002/pros.2990270606 Mirchandani, 1995, Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer, Am. J. Pathol., 147, 92 Konishi, 1995, Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma, Am. J. Pathol., 147, 1112 Gumerlock, 1997, Abnormalities in primary prostate cancer: single-strand conformational polymorphism analysis of complementary DNA in comparison with genomic DNA, J. Natl. Cancer Inst., 89, 66, 10.1093/jnci/89.1.66 Jenkins, 1997, Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostate carcinoma by fluorescence in situ hybridization, Cancer Res., 57, 524 Konishi, 1997, Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas, Am. J. Pathol., 150, 305 Lane, 1992, p53, guardian of the genome, Nature, 358, 15, 10.1038/358015a0 Kastan, 1995, P53, cell cycle control and apoptosis: implications for cancer, Cancer Metastasis Rev., 14, 3, 10.1007/BF00690207 Greenblatt, 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855 Kastan, 1992, A mammalian checkpoint pathway utilizing p53 and gadd45 is defective in ataxia-telangiectasia, Cell, 71, 587, 10.1016/0092-8674(92)90593-2 Lee, 1995, Apoptosis, cancer and the p53 tumour suppressor gene, Cancer Metastasis Rev., 14, 149, 10.1007/BF00665797 Bookstein, 1993, p53 is mutated in a subset of advanced-stage prostate cancers, Cancer Res., 53, 3369 Shibata, 1992, Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction, Am. J. Pathol., 141, 539 Kamb, 1994, A cell cycle regulator potentially involved in genesis of many tumor types, Science, 264, 436, 10.1126/science.8153634 Effert, 1992, Alterations of the TP53 gene as associated with the progression of a human prostate carcinoma, J. Urol., 147, 789, 10.1016/S0022-5347(17)37387-1 Chi, 1994, p53 in prostate cancer: frequent expressed transition mutations, J. Natl. Cancer Inst., 86, 926, 10.1093/jnci/86.12.926 Navone, 1993, p53 protein accumulation and gene mutation in the progression of human prostate carcinoma, J. Natl. Cancer Inst., 85, 1657, 10.1093/jnci/85.20.1657 Salem, 1997, p53 protein and gene alteration in pathologic stage C prostate carcinoma, J. Urol., 10.1097/00005392-199708000-00052 Dittmer, 1993, Gain of function mutations in p53, Nat. Genet., 4, 42, 10.1038/ng0593-42 Harvey, 1995, A mutant p53 transgene accelerates tumor development in heterozygotes but not nullizygous p53-deficient mice, Nat. Genet., 9, 305, 10.1038/ng0395-305 Issacs, 1997, Molecular markers for prostate cancer metastasis: developing diagnostic methods for predicting the aggressiveness of prostate cancer, Am. J. Pathol., 150, 1511 Graeber, 1996, Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours, Nature, 379, 88, 10.1038/379088a0 Kinzler, 1996, Life (and death) in a malignant tumour, Nature, 379, 19, 10.1038/379019a0